| Ytd | 17.54% | |
| 1y | 37.48% |
| Open | 79.23 | Prev Close | 78.60 | Low | 78.22 | High | 79.31 | Mkt Cap | 9.32B |
| Vol | 422.03K | Avg Vol | 1.81M | EPS | 4.62 | P/E | 17.01 | Forward P/E | 10.54 |
| Beta | 0.84 | Short Ratio | 6.94 | Inst. Own | 108.50% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 72.10 | 200-d Avg | 69.25 | 1yr Est | 83.90 |
Halozyme Therapeutics, Inc. (HALO) shares gain 539% since first Big Money outlier inflow signal in M
Halozyme grants ENHANZE rights to Incyte for developing subcutaneous cancer therapy formulations, ai
Halozyme Therapeutics, Inc. (NASDAQ:HALO) ("Halozyme" or the "Company") today announ
Agreement provides Incyte the rights to develop and commercialize ENHANZE® with its mutCALR developm
Fifth Third Bancorp increased its holdings in Halozyme Therapeutics, Inc. (NASDAQ: HALO) by 4,206.4%
ARCO, HALO, TX and ARRY screen as high-earnings-yield value picks as the Middle-East conflict sharpe
HALO stocks are gaining favor as investors rotate toward tangible assets and AI-resistant businesses
Wall Street is caught in the midst of shifting geopolitical stances of the United States and Iran, c
SAN DIEGO, June 30, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or t
SAN DIEGO, June 15, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or t
Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock?
North American railroads like UNP, NSC, CSX, CNI, and CP exhibit HALO traits: irreplaceable heavy as
Sky Harbour is building a national network of private aviation campuses on some of America's most ir
I focus on HALO investing: Heavy Assets, Low Obsolescence - owning irreplaceable physical assets wit
Investors need to pay close attention to HALO stock based on the movements in the options market lat
Halozyme Therapeutics is delivering strong shareholder value, driven by robust royalty growth and di
Acquisition gives Nexalin control of AI-integrated remote patient-monitoring, clinical data-capture
Josh Brown, co-founder and CEO of Ritholtz Wealth Management, coined the term HALO as a way to ident
Dave Mazza, CEO of Roundhill Investments, joins CNBC's "Halftime Report" to highlight the launch of
HALO beats Q1 earnings estimates as royalty revenues from partner drugs and strong product sales lif
Halozyme Therapeutics, Inc. (HALO) Q1 2026 Earnings Call Transcript
Halozyme Therapeutics, Inc. (NASDAQ:HALO) ("Halozyme" or the "Company") today announ
Tech stocks recovered on Wednesday, led by a rally in battered software names, as the Nasdaq 100 jum
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is likely to report earnings for its f
Stocks That Hit 52-Week Highs On Thursday
Stocks That Hit 52-Week Highs On Wednesday
Stocks Which Set New 52-Week Low Yesterday, October 23rd